gene editing

4 companies to watch in the accelerating gene editing race
Pharma Voice
Thu, 01/2/25 - 11:18 am
gene editing
AlgenScribe SAS
Broken String Biosciences
Caszyme
CorriXR Therapeutics
Intellia’s gene editing therapy shows early potential in rare heart condition
Clinical Trials Arena
Mon, 11/18/24 - 11:30 am
Intellia
gene editing
NTLA-2001
AHA
ATTR-CM
Editas, changing course again, looks to partner lead CRISPR therapy
BioPharma Dive
Tue, 10/22/24 - 11:45 am
Editas Medicine
gene editing
CRISPR
reni-cel
sickle cell disease
beta thalassemia
Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Fri, 10/4/24 - 09:24 am
Editas Medicine
Cas9
patents
Vertex Pharmaceuticals
gene editing
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
Fierce Pharma
Tue, 09/24/24 - 09:51 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Lonza
Casgevy
Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching
BioSpace
Fri, 08/23/24 - 11:11 am
Tome Bioscience
gene editing
Vertex, Orum partner on safer pre-treatment for gene meds
Pharmaphorum
Wed, 07/17/24 - 11:48 am
Vertex Pharma
Orum Therapeutics
gene editing
Beacon lights up with $170m for retinal disease gene therapy
Pharmaphorum
Wed, 07/3/24 - 11:21 am
Beacon Therapeutics
funding
gene editing
X-linked retinitis pigmentosa
retinal diseases
First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
BioPharma Dive
Wed, 06/26/24 - 10:00 am
Intellia Therapeutics
CRISPR
gene editing
transthyretin amyloidosis
Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight
Fierce Biotech
Thu, 05/2/24 - 10:17 pm
Moderna Therapeutics
Metagenomi
gene editing
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive
Thu, 04/25/24 - 11:31 am
Regeneron
Mammoth Biosciences
CRISPR
gene editing
Lilly's Prevail walks away from gene editing collab with Precision
Fierce Biotech
Wed, 04/17/24 - 11:11 am
Eli Lilly
Prevail Therapeutics
gene editing
Precision Biosciences
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
BioSpace
Wed, 03/13/24 - 10:39 am
Ricoh
ERS Genomics
gene editing
CRISPR
Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup
BioPharma Dive
Wed, 02/28/24 - 11:09 am
Ginkgo Bioworks
M&A
Proof Diagnostics
gene editing
Feng Zhang
Gene-editing firm Prime Medicine files $140m public offer
Pharmaphorum
Thu, 02/15/24 - 11:17 am
Prime Medicine
funding
gene editing
Gene editing biotech Metagenomi pulls off nearly $94M IPO
BioPharma Dive
Sun, 02/11/24 - 03:52 pm
IPOs
Metagenomi
gene editing
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia’s CRISPR drug could offer one-shot HAE treatment
Pharmaphorum
Thu, 02/1/24 - 11:26 am
Intellia Therapeutics
HAE
clinical trials
CRISPR
gene editing
NTLA-2002
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
CRISPR Therapeutics
gene editing
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics

Pages